CROs worldwide rely on Gyrolab^® technology

For many preclinical and bioanalytical contract research organizations (CROs) and their clients working in the development and production of biotherapeutics, Gyrolab is recognized as a must-have technology for preclinical and bioprocessing immunoassays such as PK, immunogenicity, and host cell protein (HCP) analysis. CROs value Gyrolab platform benefits of:

• Rapid assay development
• Short turnaround time
• Small sample volumes requirements
• Broad dynamic range
• Robust assays
• Easier assay transfer

For a complete list of CROs offering Gyrolab services, contact your local representative.